Skip to main content
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2005 Jun 24;24(17):2669–2679. doi: 10.1002/sim.2131

The probability of failing in detecting an infectious disease at entry points into a country

M Dell'Omodarme 1, M C Prati 1,2,
PMCID: PMC7169602  PMID: 15977301

Abstract

In a group of N individuals, carrying an infection with prevalence π, the exact probability P of failing in detecting the infection is evaluated when a diagnostic test of sensitivity s and specificity s′ is carried out on a sample of n individuals extracted without replacement from the group. Furthermore, the minimal number of individuals that must be tested if the probability P has to be lower than a fixed value is determined as a function of π. If all n tests result negative, confidence intervals for π are given both in the frequentistic and Bayesian approach. These results are applied to recent data for severe acute respiratory syndrome (SARS). The conclusion is that entry screening with a diagnostic test is rarely an efficacious tool for preventing importation of a disease into a country. Copyright © 2005 John Wiley & Sons, Ltd.

Keywords: diagnostic test, SARS, detection failure, prevalence estimation, Bayesian approach

REFERENCES

  • 1. Gart JJ, Buck AA. Comparison of a screening test and a reference test in epidemiologic studies. American Journal of Epidemiology 1966; 85(3):593–602. [DOI] [PubMed] [Google Scholar]
  • 2. Rogan WJ, Gladen B. Estimating prevalence from the results of a screening test. American Journal of Epidemiology 1978; 107(1):71–76. [DOI] [PubMed] [Google Scholar]
  • 3. Quade D, Lachenbruch PA, Whaley FS, McClish DK, Haley RW. Effects of misclassifications on statistical inferences in epidemiology. American Journal of Epidemiology 1980; 111(5):503–515. [DOI] [PubMed] [Google Scholar]
  • 4. Walter SD, Irwing LM. Estimation of test error rates, disease prevalence and relative risk from misclassified data: a review. Journal of Clinical Epidemiology 1988; 41(9):923–937. [DOI] [PubMed] [Google Scholar]
  • 5. Tu XM, Litvak E, Pagano M. On the informativeness and accuracy of pooled testing in estimating prevalence of a rare disease: application to HIV screening. Biometrika 1995; 82:287–297. [Google Scholar]
  • 6. Yam WC, Chan KH, Poon LL, Guan Y, Yuen KY, Seto WH, Peiris JS. Evaluation of reverse transcription‐PRC assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus. Journal of Clinical Microbiology 2003; 41(10):4521–4524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Wilder‐Smith A, Paton NI, Goh KT. Experience of severe acute respiratory syndrome in Singapore: importation of cases, and defense strategies at the airport. Journal of Travel Medicine 2003; 10(5):259–262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Samaan G, Patel M, Spencer J, Roberts L. Border screening for SARS in Australia: what has been learnt? The Medical Journal of Australia 2004; 180:220–223. [DOI] [PubMed] [Google Scholar]
  • 9. Petrosillo N, Puro V, Ippolito G. Border screening for SARS. The Medical Journal of Australia 2004; 180:597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Cameron AR, Baldock FC. A new probability formula for surveys to substantiate freedom from disease. Preventive Veterinary Medicine 1998; 34:1–17. [DOI] [PubMed] [Google Scholar]
  • 11. Gradshteyn IS, Ryzhik IM. Table of Integrals, Series, and Products. Academic Press: New York, 1980. [Google Scholar]
  • 12. Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. New England Journal of Medicine 2003; 348:1967–1976. [DOI] [PubMed] [Google Scholar]
  • 13. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S et al. A novel coronavirus associated with severe acute respiratory syndrome. New England Journal of Medicine 2003; 348:1953–1966. [DOI] [PubMed] [Google Scholar]
  • 14. Armitage P, Berry G, Matthews JNS. Statistical Methods in Medical Research (4th edn). Blackwell Publishing: Oxford, 2002. [Google Scholar]
  • 15. Gelfand AE, Smith AFM. Sampling‐based approaches to calculating marginal densities. Journal of American Statistical Association 1990; 85:398–409. [Google Scholar]
  • 16. Joseph L, Gyorkos TW, Coupal L. Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standard. American Journal of Epidemiology 1995; 141(3):263–272. [DOI] [PubMed] [Google Scholar]
  • 17. R Development Core Team . R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing Vienna, Austria, 2003.

Articles from Statistics in Medicine are provided here courtesy of Wiley

RESOURCES